Complications of UTI in patients on dapagliflozin

Trial Identifier:	D1690R00008
Sponsor:	AstraZeneca
NCTID::	NCT02695173
Start Date:	January 2017
Primary Completion Date:	September 2020
Condition:	Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom
United States of America, DE	Wilmington, DE, United States of America
United States of America, Washington DC	Washington DC, United States of America

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.